Image

Global Gastroenteritis Testing Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Gastroenteritis Testing Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gastroenteritis Testing Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.80 USD Billion
Diagram Market Size (Forecast Year) USD 5.61 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Gastroenteritis Testing Market, By Disease Strains (Bacterial Strains, Viral Strains, Parasitic Strains), Product Type (Reagent Kits, Sequencing Kits and Equipment), Testing Methods (Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing), End-User (Hospitals, Clinics/Medical Centers, Research Institutes, Diagnostic Laboratories) – Industry Trends and Forecast to 2030.

Gastroenteritis Testing Market

 Gastroenteritis Testing Market Analysis and Size

The rising prevalence of abdominal pain caused by gastrointestinal infections caused by viral, parasitic, or bacterial infections is driving the gastrointestinal testing market. Furthermore, rising digestive issues caused by poor eating habits will drive growth in the global gastrointestinal testing market.

Data Bridge Market Research analyses that the gastroenteritis testing market which was USD 3.8 billion in 2022, is expected to reach USD 5.61 billion by 2030, at a CAGR of 5.0% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Gastroenteritis Testing Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Disease Strains (Bacterial Strains, Viral Strains, Parasitic Strains), Product Type (Reagent Kits, Sequencing Kits and Equipment), Testing Methods (Immunoassay Testing, Conventional Testing, Molecular Diagnostic), End-User (Hospitals, Clinics/Medical Centers, Research Institutes, Diagnostic Laboratories)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

BD (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), Amgen Inc. (U.S.), Hainan Poly Co. Ltd (China), WOCKHARDT (India)

Market Opportunities

  • High-end efficiency of biologics

Market Definition

Global Gastroenteritis Testing Market Dynamics

Drivers

  • Increased Gastrointestinal Disorders

According to the Centers for Disease Control and Prevention (CDC), approximately 1-1.3 million people in the United States suffer from Inflammatory Bowel Disease (IBD). Crohn's disease and ulcerative colitis have incidence rates of 201 and 238 per 100,000 adults, respectively. As a result, market growth is boosted.

  • Higher Rate of Drug Approvals and Launches    

A wide range of new generation therapeutics targets, including novel small molecules and cellular therapy, are currently being developed. Mongersen, tofacitinib, ustekinumab, and vedolizumab are examples. This influx is expected to be a result of the global rise in the prevalence of gastrointestinal diseases. Furthermore, Vedolizumab is being developed as a first-line biologic therapy for Crohn's disease. The US Food and Drug Administration has approved Humira, Amjevita, Remicade, Renflexis, Cimzia, Inflectra, Tysabri, and Entyvio to treat Crohn's disease. As a result, all of these developments are boosting market growth.

Opportunities

  • High-end Efficiency of Biologics

According to some studies, biologics have higher long-term efficiency. According to a University of Chicago study, the use of biologics has resulted in a 40.0% reduction in the number of surgeries, a 60.0% reduction in emergency room visits, and a 50% reduction in hospitalizations. All of these factors are also contributing to the market's growth.

Restraints/Challenges

  • Unavailability of Appropriate Treatments

Many times, all treatments are not available to treat rare conditions, particularly in developing countries. Severe patients require advanced techniques, which are not always available in hospitals and clinics. As a result, it stifles market growth.

This gastroenteritis testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gastroenteritis testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Gastroenteritis Testing Market

During the pandemic, gastrointestinal disorders were found to be significantly associated with COVID-19 patients. The severity of COVID-19 is combined with a set of comorbidities such as diabetes, obesity, hypertension, and/or advanced age, which significantly exacerbates the infection's consequences. Additionally, gastrointestinal symptoms such as vomiting, diarrhoea, or abdominal pain are observed during the early stages of COVID-19. Thus, during COVID-19, diagnosing gastrointestinal symptoms that lead to respiratory problems became critical for early detection and treatment. As a result, COVID-19 significantly impacted the global gastroenteritis testing market.

Global Gastroenteritis Testing Market Scope

The gastroenteritis testing market is segmented on the basis of disease strains, product type, testing methods and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Strains

  • Bacterial Strains
  • Viral Strains
  • Parasitic Strains

 Product Type

  • Reagent Kits
  • Sequencing Kits and Equipment

Testing Methods

  • Immunoassay Testing
  • Conventional Testing
  • Molecular Diagnostic Testing

 End-User

  • Hospitals
  • Clinics/Medical Centers
  • Research Institutes
  • Diagnostic Laboratories

Gastroenteritis Testing Market Regional Analysis/Insights

The gastroenteritis testing market is analyzed and market size insights and trends are provided by country, disease strains, product type, testing methods and end-user as referenced above.

The countries covered in the gastroenteritis testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gastroenteritis testing market due to increased awareness among people along with extensively increasing demand for technologically advanced diagnostic testing products.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing technological advancements.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The gastroenteritis testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gastroenteritis testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gastroenteritis testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Gastroenteritis Testing Market Share Analysis

The gastroenteritis testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gastroenteritis testing market.

Some of the major players operating in the gastroenteritis testing market are:

  • BD (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Merck & Co., Inc. (U.S.)
  • Lilly (U.S.)
  • Amgen Inc. (U.S.)
  • Hainan Poly Co. Ltd (China)
  • WOCKHARDT (India)

Research Methodology: Global Gastroenteritis Testing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Gastroenteritis Testing Market size will be worth USD 5.61 billion by 2030.
The Gastroenteritis Testing Market growth rate is 5.0% by 2030.
The Increased Gastrointestinal Disorders, Higher Rate of Drug Approvals and Launches are the growth drivers of the Gastroenteritis Testing Market.
The disease strains, product type, testing methods, and end-user are the factors on which the Gastroenteritis Testing Market research is based.
The major companies in the Gastroenteritis Testing Market are BD (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), Amgen Inc. (U.S.), Hainan Poly Co. Ltd (China), WOCKHARDT (India).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials